FEB 09, 2022 9:00 AM PST

An Approach to Ultrasensitive Detection and Quantification of Copy Number Variations (CNVs) and Mutations

Sponsored by: Nuprobe
C.E. Credits: P.A.C.E. CE Florida CE
Speakers

Abstract
Date:  February 09, 2022
Time: 09:00am (PST),  12:00pm (EST)
 
In this webinar we will introduce Quantitative Amplicon Sequencing (QASeq): a highly sensitive and robust NGS-based method for the detection and quantification of low frequency Copy Number Variations (CNVs) and Single Nucleotide Variants (SNVs) in a wide range of sample types including fresh frozen, FFPE, and cell-free DNA. We will demonstrate that QASeq can accurately detect CNVs down to 5% heterozygous single copy gain or loss (ploidy=2.05/1.95). Additionally, we will introduce NuProbe’s custom assay development program.
 
Learning Objectives
 
By the end of the webinar, the attendees will be able to:
  • Identify main challenges of current methods (IHC, FISH, NGS, and PCR) for sensitive CNV calling and learn how NuProbe’s ultrasensitive QASeq NGS technology for tissue and liquid biopsy applications can overcome these challenges.
  • Review NuProbe's proprietary QASeq technology to increase sensitivity and describe the construction and validation of NuProbe’s custom assays.
  • Illustrate the process of developing and validating QASeq NGS panels for the simultaneous for the simultaneous and ultrasensitive detection of CNVs and mutations in the ERBB2 gene as well as other target genes.
  • Provide an overview of custom assay development and validation for biopharma and research applications.

 

Disclaimer: Products are for research use only, not for use in diagnostic procedures.
 
Webinars will be available for unlimited on-demand viewing after live event.
 
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

Show Resources
You May Also Like
JUN 21, 2022 6:00 AM PDT
JUN 21, 2022 6:00 AM PDT
Date: June 21, 2022 Time: 6:00am (PDT), 9:00am (EDT), 3:00pm (CEST) The global understanding and practice of medicine is currently undergoing a revolutionary change. This shift to precision...
MAR 16, 2022 8:00 AM PDT
C.E. CREDITS
MAR 16, 2022 8:00 AM PDT
Date: March 16, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CET) Handling of potent and/or hazardous substances is commonplace in sev.....
MAY 17, 2022 9:00 AM PDT
MAY 17, 2022 9:00 AM PDT
Date: May 17, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Gene therapeutics have great potential to treat many severe diseases in an unprecedented, targeted manner. The biopharmace...
DEC 01, 2021 7:00 AM PST
C.E. CREDITS
DEC 01, 2021 7:00 AM PST
Date: December 01, 2021 Time: 7:00am (PST), 10:00am (EST) In the era of immuno-oncology, there is a growing need for the identification of new biomarkers predictive for sensitivity to anti-P...
MAR 23, 2022 11:00 AM PDT
MAR 23, 2022 11:00 AM PDT
Date: March 23, 2021 Time: 11:00am (PDT), 2:00pm (EDT), 8:00pm (CEDT) In this presentation, Dr. Middleton will review the development and deployment of large-scale saliva-based COVID-19 test...
NOV 30, 2021 10:00 AM PST
C.E. CREDITS
NOV 30, 2021 10:00 AM PST
Date: November 30, 2021 Time: 10:00am (PDT), 1:00pm (EDT) The prevalence of thyroid disease worldwide has served as a catalyst for healthcare providers to study various tools and methods to...
Loading Comments...
Show Resources